CoChat

Muscle-Specific Promoters May Be Necessary for Adeno-Associated Virus-Mediated Gene Transfer in the Treatment of Muscular Dystrophies

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Recombinant adeno-associated virus (rAAV) vectors allow efficient gene transfer and expression in the muscle; therefore, rAAVs represent a potential gene therapy vector for muscular dystrophies. For further investigations, we used a mouse muscular dystrophy model (gsg(-/-) mice) gamma-sarcoglycan, a subunit of the dystrophin-glycoprotein complex, is missing. gsg(-/-) mice develop progressive dystrophy representative of a severe human phenotype disease. We previously showed high levels and stable expression of gamma-sarcoglycan in myofibers after direct muscle injection into gsg(-/-) mice of a recombinant AAV vector (AAV.dMCK.gSG) carrying the gamma-sarcoglycan cDNA driven by a muscle-specific promoter (truncated version of muscle creatine kinase). Here, we show that when gamma-sarcoglycan expression is driven by the ubiquitous cytomegalovirus (CMV) promoter (AAV.CMV.gSG), lower levels of transgene expression are observed and are associated with a humoral response to gamma-sarcoglycan. When using an rAAV vector, expressing the highly immunogenic product gamma-galactosidase under the CMV promoter (AAV.CMV.LacZ), we measured a strong cellular and humoral immune response to the transgene after intramuscular injection into gsg(-/-) mice. This study suggests that restriction of transgene expression to the muscle is an important criterion for the treatment of muscular dystrophies and will aid in the design of protocols for gene therapy.

Overview

Integrity signals

Registry

Crossref · 10.1089/104303401750061267

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 5

  1. ABINA M.A., 1996, Gene Ther., 3, 212
  2. BROCKSTEDT D.G., 1999, J. Appl. Biomater., 92, 67
  3. MCNALLY E.M., 1996, Am. J. Hum. Genet., 59, 1040
  4. YANG Y., 1996, Gene Ther., 3, 137
  5. YANG Y., 1996, Gene Ther., 3, 412

Cited by

See all 152

Metadata

Authors
Cordier, L., Gao, G.-P., Hack, A. A., McNally, E. M., Wilson, J. M., Chirmule, N., & Sweeney, H. L.
Affiliations
  • University of Pennsylvania (US)
  • Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia, PA 19104
  • University of Chicago (US)
Venue
Human Gene Therapy
Published
2001-01-20
Volume
12
Issue
2
Pages
205-215
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2174994066
Cited by
152
References
42
Citations by year
2026: 5 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 3 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 7
FWCI
7.46
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations
  • Human Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR/NS43648)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus vectors, gene therapy, muscular dystrophy, muscle-specific promoter, cytomegalovirus promoter, gamma-sarcoglycan, dystrophin-glycoprotein complex, humoral immune response, intramuscular injection, gene transfer
MeSH terms
Dependovirus, Animals, Antigen-Presenting Cells, beta-Galactosidase, Creatine Kinase, Cytoskeletal Proteins, Dendritic Cells, Genetic Vectors, Humans, Immunoenzyme Techniques, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Mutant Strains, Muscular Dystrophies, Promoter Regions, Genetic, T-Lymphocytes, Cytotoxic, Transduction, Genetic, Blotting, Western, Dystrophin, Gene Transfer Techniques, Muscle, Skeletal, Sarcoglycans, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Muscle-Specific Promoters May Be Necessary for Adeno-Associated Virus-Mediated Gene Transfer in the Treatment of Muscular Dystrophies. https://app.cochat.ai/papers/10.1089/104303401750061267
The paper
Cordier, L., Gao, G.-P., Hack, A. A., McNally, E. M., Wilson, J. M., Chirmule, N., & Sweeney, H. L. (2001). Muscle-Specific Promoters May Be Necessary for Adeno-Associated Virus-Mediated Gene Transfer in the Treatment of Muscular Dystrophies. Human Gene Therapy. https://doi.org/10.1089/104303401750061267

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.